News
Stay Ahead with the Latest Industry Trends & Market Insights with Industry News 📰

Albumin and Creatinine Tests Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: June 2024 || SKU: PH3318
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Get Free Sample

See how US Tariffs impact Albumin and Creatinine Tests Market

Don’t get

Global Albumin And Creatinine Tests Market is segmented By Product (Analyzers, Cartridges (PoC, Tabletop), Dipsticks Kits, Reagents), By Type (Blood & Urine Creatinine, Urine Albumin, Glycated Albumin), By End-User (Hospital, Diagnostic laboratories, Research Laboratories & Institutes), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031

 

Albumin and Creatinine Tests Market Overview

The Global Albumin & Creatinine Tests Market is expected to grow at a high CAGR during the forecast period (2024-2031).

Albumin & creatinine test is a type of urine test. The albumin to creatinine ratio in the urine is checked through this test to determine kidney disease in people with chronic conditions. This function is highly beneficial for early diagnosis and quick treatment. The growing concerns related to the increasing cases of kidney disorders and diseases may serve as vital growth generators for the albumin & creatinine tests market. The escalating prevalence of diabetes and high blood pressure is also expected to increase the growth rate of the albumin & creatinine test markets as these chronic conditions lead to kidney problems.

 

Albumin and Creatinine Tests Market Summary

Metrics

Details

Market CAGR

High

Segments Covered

By Product, By Type, By End-User, and By Region

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.

Fastest Growing Region

Asia Pacific

Largest Market Share 

North America

 

For More Insights - Request Free Sample
 

Albumin and Creatinine Tests Market Dynamics

The high prevalence of kidney disorders is driving the demand for albumin and creatinine tests. Biochemical urine analysis enables clinicians to access the level of compounds that involve creatinine, urobilinogen, bilirubin, ketones, and glucose in the urine drives the demand for ACR tests resulting in the growth of the global market. Therefore, rising cases of kidney diseases are the primary growth factor that enables the demand for the albumin and creatinine tests market.

Increasing Prevalence of Kidney Disorders

Kidney disorders and diseases are accelerating in terms of the prevalence rate, primarily among a young chunk of the populace. This aspect may serve as a vital growth indicator for the albumin & creatinine tests market during the forecast period. The escalating rate of hypoalbuminemia caused due to the novel coronavirus will further encourage individuals to undertake albumin & creatinine tests, eventually increasing the growth rate.

Increased use of integrated systems

The emergence of integrated systems may invite profitable growth for the albumin & creatinine tests market during the assessment period. Large hospitals and diagnostic laboratories are making use of these integrated systems for managing their work. Thus, the heightening utilization of integrated devices to allow quick analysis of urine samples will invite good growth opportunities for the albumin & creatinine tests market.

COVID-19 Impact Analysis

COVID-19 pandemic affected the global economy in many terms, such as directly affecting production and demand, supply chain disruption, and financial impact. COVID-19 has directly impacted the manufacturers' supply chain across the globe and shut down the production facilities to minimize the risk of virus spread. Also, the pandemic has strengthened the demand for albumin & creatinine tests across the globe. The test determines various kidney diseases therefore, the overall albumin & creatinine market showed positive growth during the forecast period.

Albumin and Creatinine Tests Market Segment Analysis

Based on the Product, the albumin & creatinine tests market has been classified into the analyzer, cartridges (PoC, Tabletop), Dipsticks Kits, and Reagents.

The dipsticks & kits products segment accounted for the largest share

The dipsticks & kits segment accounted for the largest share in this market. The frequent purchase of these products compared to instruments like analyzers and cartridges and the increasing use of kit-based rapid techniques for albumin & creatinine tests drive market growth.

Based on type, the albumin & creatinine tests market is segmented into urine tests and blood & serum creatinine tests.

Urine Tests segment to register the highest growth rate during the forecast period

Urine tests accounted for the largest share in this market. Factors such as the rapid growth in the diagnostics segment and the increasing demand for rapid and easy-to-use urine tests drive the growth of this segment.

Albumin and Creatinine Tests Market Geographical Share

Based on geography, the study analyzes the albumin & creatinine tests market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

North America leads the global market throughout the forecast period

North America accounted for the largest share in the global market. The large share of this regional segment can primarily be attributed to the growth in demand for rapid urine tests, increasing prevalence of chronic conditions leading to various kidney diseases, rising government initiatives, and growing geriatric population.

The Asia Pacific albumin & creatinine tests market is estimated to grow at a significantly higher rate during the forecast period, mainly due to the expansion of key market players in emerging Asian countries, increasing expenditure on life science and medical research in the region, and the increasing geriatric population and prevalence of chronic conditions in Asian countries such as India and China.

Albumin and Creatinine Tests Market Companies and Competitive Landscape

The albumin & creatinine tests market is highly competitive, owing to the presence of big brands. The key albumin & creatinine players which are contributing to the growth of the global market include Randox Laboratories, Raybiotech, Inc., Roche Diagnostics (A Division of F. Hoffman-La Roche Ag), Sekisui Diagnostics Pei Inc., Siemens Healthineers Ag, Sysmex Corporation, Teco Diagnostics, Thermo Fisher Scientific, Inc. The major players are adopting new product launch and expansion strategies for global growth in the albumin & creatinine tests market.   

Randox Laboratories

Overview: Randox Laboratories Ltd. is a privately owned diagnostic reagent and equipment manufacturer and the leading British manufacturer of clinical chemistry reagents. Randox has over 25 years of experience in the research, development, manufacture and marketing of high-quality diagnostic reagents and equipment for laboratory medicine.

The Randox portfolio includes the revolutionary Biochip Array Technology for application in genomics and proteomics, clinical chemistry automation systems, external quality assurance schemes, internet-driven QC systems, quality control materials, clinical reagents and environmental diagnostics. The life sciences department offers a range of polyclonal antibodies and recombinant proteins, and the customer service team offers an assay development service. Randox is a significant investor in the development of new healthcare technology solutions. The Company’s headquarters is located at Crumlin, United Kingdom

Product Portfolio: The company's portfolio comprises biochip array technology, clinical chemistry analysers and reagents, quality control materials and software, and an extensive biosciences portfolio.

Why Purchase the Report?

  • Visualize the albumin & creatinine tests market segmentation composition by product, type, end-user, and region, highlighting the critical commercial assets and players.
  • Identify commercial opportunities in the albumin & creatinine tests market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of albumin & creatinine tests market - level 3 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global albumin & creatinine tests market report would provide access to an approx. 57 market data table, 55 figures and 180 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers
Buy this report
Single User
$4350$3480
Multiple User
$4850$3880
Enterprise User
$7850$6280
Proceed to Buy
  Get Free Sample
  Request new version
  Customize Sample
  Demo Full Report
Chat on WhatsApp
FAQ’s

  • The segments are By Product, By Type, By End-User, and By Region

  • Key players are Randox Laboratories, Raybiotech, Inc., Roche Diagnostics (A Division of F. Hoffman-La Roche Ag), Sekisui Diagnostics Pei Inc., Siemens Healthineers Ag, Sysmex Corporation, Teco Diagnostics, Thermo Fisher Scientific, Inc.
Related Reports
pharmaceuticals iconpharmaceuticals

Coloboma Treatment Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2023 September 26

Starting from

$4350

pharmaceuticals iconpharmaceuticals

Color Blindness Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2023 September 26

Starting from

$4350

pharmaceuticals iconpharmaceuticals

Typhoid Fever Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2023 September 25

Starting from

$4350

pharmaceuticals iconpharmaceuticals

Foveal Atrophy Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2023 September 26

Starting from

$4350

pharmaceuticals iconpharmaceuticals

Renal Insufficiency Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 December 18

Starting from

$4350

pharmaceuticals iconpharmaceuticals

Liposarcoma Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 December 18

Starting from

$4350

WhatsApp